Coronavirus Update: J&J’s Single Dose Stands Out From COVID Vaccine Crowd

Phase III Planned For September

 
• By Scrip Team

J&J is a few months behind companies like Moderna, Pfizer and AstraZeneca in the race to develop a vaccine, but a safe and effective single dose immunization would be a game changer.

Manchester_Metro
Manchester, UK: restrictions on social gatherings were reintroduced in the city after rates of transmission began rising again • Source: Shutterstock

More from COVID-19

More from Scrip